No Data
No Data
Argenx Plunges After Q1 Revenue Miss
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator
Express News | Shares of Vaccine and Gene Therapy Stocks Are Trading Lower After FDA Commissioner Marty Makary Reportedly Named Vinay Prasad as Director of the Center for Biologics and Research
Express News | 'FDA Names Vinay Prasad as New Head of Vaccines, Biologics'- Bloomberg Law
These Are the Sectors Best Liked Within Defensive and Cyclicals Groups – Morgan Stanley